UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038390
Receipt number R000043748
Scientific Title Study for the determining factor of arterial FDG uptake in inflammatory arterial diseases.
Date of disclosure of the study information 2019/10/25
Last modified on 2022/04/27 19:50:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for the determining factor of arterial FDG uptake in inflammatory arterial diseases.

Acronym

FDG uptake in inflammatory arterial diseases.

Scientific Title

Study for the determining factor of arterial FDG uptake in inflammatory arterial diseases.

Scientific Title:Acronym

FDG uptake in inflammatory arterial diseases.

Region

Japan


Condition

Condition

inflammatory arterial diseases

Classification by specialty

Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analysing the factors which determine arterial wall uptake of FDG.

Basic objectives2

Others

Basic objectives -Others

Evaluation of ethiology

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Relationship between FDG uptake on arterial wall and other biological parameters.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient with large vessel vasculitis, IgG4-related disorder and polymyalgia rheumatica

Key exclusion criteria

Patient who showed glucose level over 250mg/dl at the time of FDG PET examination.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Kudo

Organization

Nagasaki University

Division name

Dept.of Radioisotope medicine, Atomic bomb disease institute.

Zip code

852-8523

Address

1-12-4 Sakamoto, Nagasaki

TEL

0958197101

Email

tkudo123@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Kudo

Organization

Nagasaki University

Division name

Dept.of Radioisotope medicine, Atomic bomb disease institute.

Zip code

8528523

Address

1-12-4 Sakamoto, Nagasaki

TEL

0958197101

Homepage URL


Email

tkudo123@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Nagasaki University Hospital

Address

1-7-1 Sakamoto, Nagasaki

Tel

095-819-7229

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 20 Day

Date of IRB

2019 Year 10 Month 22 Day

Anticipated trial start date

2019 Year 11 Month 01 Day

Last follow-up date

2021 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2019 Year 10 Month 25 Day

Last modified on

2022 Year 04 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043748